The excessive cosolute densities in the intracellular fluid create a physicochemical condition called macromolecular crowding (MMC). Intracellular MMC entropically maintains the biochemical ...

Last fall’s booster was designed to target the omicron variant circulating in 2023. This year, mRNA vaccines made by Moderna and Pfizer and the protein-based vaccine from Novavax — which has yet to be ...

The protocol number is ZJU20220375. Tg(gsc:EGFP;sox17:dsRed) embryos and Nodal explants generated from those embryos were used to perform live imaging analysis. 0.5% low-melt agarose was used to mount ...

The mRNA COVID-19 vaccines have been administered to hundreds of millions of people in the U.S., and the benefits of these vaccines continue to outweigh their risks, the FDA said.

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Yes ...

Moderna, Inc.'s combination flu and COVID-19 vaccine, mRNA-1083, showed strong Phase 3 results in adults over 50. Pfizer/BioNTech's combination vaccine faced setbacks, giving Moderna a potential ...

BioNTech has announced the initiation of global clinical trials for BNT116, an mRNA vaccine for the potential treatment of non-small cell lung cancer (NSCLC). The vaccine is claimed to use the ...

The vaccine is claimed to use the same mRNA technology that proved instrumental in Covid-19 vaccines. Credit: Kitsawet Saethao/Shutterstock. BioNTech has announced the initiation of global clinical ...

The mRNA revolution continues. Just a few years after mRNA vaccines proved their efficacy against COVID-19, scientists are now turning their attention to lung cancer. The mRNA vaccine, known as ...

Using mRNA technology similar to Covid-19 vaccines, BNT116 aims to enable the immune system to target NSCLC tumour markers, attacking cancer cells while sparing healthy ones. Lung cancer is the ...